AI-assisted synthesis prediction.

Journal: Drug discovery today. Technologies
Published Date:

Abstract

Application of AI technologies in synthesis prediction has developed very rapidly in recent years. We attempt here to give a comprehensive summary on the latest advancement on retro-synthesis planning, forward synthesis prediction as well as quantum chemistry-based reaction prediction models. Besides an introduction on the AI/ML models for addressing various synthesis related problems, the sources of the reaction datasets used in model building is also covered. In addition to the predictive models, the robotics based high throughput experimentation technology will be another crucial factor for conducting synthesis in an automated fashion. Some state-of-the-art of high throughput experimentation practices carried out in the pharmaceutical industry are highlighted in this chapter to give the reader a sense of how future chemistry will be conducted to make compounds faster and cheaper.

Authors

  • Simon Johansson
    Hit Discovery, Discovery Sciences, R&D, AstraZeneca Gothenburg, Sweden; Department of Computer Science and Engineering, Chalmers University of Technology, Gothenburg, Sweden. Electronic address: simon.johansson@astrazeneca.com.
  • Amol Thakkar
    Hit Discovery, Discovery Sciences, R&D, AstraZeneca Gothenburg, Sweden; Department of Chemistry and Biochemistry, University of Bern, Freiestrasse 3, 3012 Bern, Switzerland.
  • Thierry Kogej
    AstraZeneca , Gothenburg 431 83, Sweden.
  • Esben Bjerrum
    Hit Discovery, Discovery Sciences, R&D, AstraZeneca Gothenburg, Sweden.
  • Samuel Genheden
    Hit Discovery, Discovery Sciences, R&D, AstraZeneca Gothenburg, Sweden.
  • Tomas Bastys
    Hit Discovery, Discovery Sciences, R&D, AstraZeneca Gothenburg, Sweden.
  • Christos Kannas
    Department of Data Science, The Institute of Cancer Research, London SM2 5NG, UK.
  • Alexander Schliep
    Department of Computer Science and Engineering, University of Gothenburg, Gothenburg, Sweden.
  • Hongming Chen
    Hit Discovery, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, 431 83, Mölndal, Sweden.
  • Ola Engkvist
    Hit Discovery, Discovery Sciences, Innovative Medicines and Early Development Biotech Unit, AstraZeneca R&D Gothenburg, 431 83, Mölndal, Sweden.